Yahoo Finance

Enable Injections Announces enFuse® System Regulatory Approval in Brazil and MRHA Medical Device Registration in the UK

CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® on-body drug delivery system, announced ...
Yahoo Finance

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories

CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, and ...
MarketWatch

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

The MarketWatch News Department was not involved in the creation of this content. CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company ...
Business Insider

Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi

CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), today ...
manilatimes

Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology

CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced that ...
Business Insider

Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare ...
MarketWatch

Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) in Sobi Territories

The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...